Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 40 (MTND5P40) is a nuclear DNA pseudogene derived from the mitochondrial gene MT-ND5, which encodes NADH dehydrogenase subunit 5, a component of mitochondrial Complex I. Pseudogenes like MTND5P40 result from genomic insertions of mitochondrial DNA into nuclear chromosomes (known as NUMTs) and are nonfunctional remnants that do not encode active protein[7][8]. While the active MT-ND5 gene is crucial for mitochondrial electron transport and is linked to several neurodegenerative and metabolic disorders, the pseudogene MTND5P40 has no known functional, biological, or therapeutic relevance[7]. There is nothing to suggest MTND5P40 encodes a receptor, enzyme, transporter, or has any drug interaction or therapeutic value—it is a noncoding pseudogene. It should not be mistaken for the functional mitochondrial MT-ND5 gene, which is an important bioenergetic enzyme[1][3][4][5][6]. The BioGPS gene report confirms that MTND5P40 is a pseudogene record with no described protein product or biological activity[7].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 40 (MTND5P40).